A Brighter Prognosis for Aplastic Anemia

Science advances and Treatments improve.  Here's what US News and World Report has to say.

But there's hope: Considered fatal as recently as two decades ago, aplastic anemia is becoming a far more manageable disease. Advances in drug therapies and improvements in the field of transplantation have slashed the death toll, allowing patients to live longer, fuller lives.

"We are getting better at treating aplastic anemia, either in getting rid of it or treating its symptoms," said Dr. Jaroslaw P. Maciejewski, with the Cleveland Clinic's Department of Hematologic Oncology and Blood Disorders.

Source:  USNews and World Report:  Aplastic Anemia

 


Procrit for Aplastic Anemia?

This blog posts questions whether Procrit is effective for Aplastic Anemia Treatment:  Obviously please make your own decision with your doctor.

Is aranesp considered medically necessary for aplastic anemia?

Erytropoietin levels are elvevated in apalstic anemia patients. This raised the probability that additional exogenous erythropoietin may not be effective. However, despite the same concern, erythropoietin is effective in  in myelodysplastic syndrome. I reference a Japanese editorial that advocated the use of erythropoietin ( and this would include darbepoetin) for aplastic anemia.


Source:  Aplastic Anemia Treatment and Procrit

Are you a match? Register to be a Donor

Bone marrow transplants continue to be an important Aplastic Anemia Treatment.  If you are in Canada, read this article.

A better chance to find a match
Blood donors can now register online, use mail-in swab kits
By JOHN GILLIS Health Reporter
Fri. Feb 29 - 7:11 AM

FINDING A match for a person who needs donat­ed blood, cells or mar­row can be like finding a needle in a haystack.

Now potential donors can better a sick person’s odds without getting needles them­selves.

At Canadian Blood Services’ new website onematch.ca, peo­ple can register to be donors and be mailed a cheek swab kit. Donors can then take swabs and mail them back to have their DNA entered in a data­base.

Each new registrant could be a match for a person any­where in the world. Sue Smith, executive direc­tor of the OneMatch Stem Cell and Marrow Network, said it’s especially important that peo­ple from different ethnic com­munities join the registry.

“The face of Canada is changing dramatically," she said in a news release. “The more diverse One­Match is, the better the odds to save lives."

While Caucasians in Canada who need stem cell transplants have about a 75 per cent chance of finding a donor, aboriginal, black, Chinese, South Asian and Filipino Canadians don’t stand as good a chance because there aren’t enough available donors from those communi­ties.

It is more likely a donor will come from a person’s own com­munity.

Ifeoma Obi, who immigrated to Canada from Nigeria, has sickle cell disease and requires regular blood transfusions.

“I want to personally thank people for helping me enjoy a better quality of life," Ms. Obi said in a release.

“And I want them to encour­age their friends and family to become blood donors so that they too can save a life like mine."

People with sickle cell or aplastic anemia need donors who are precisely matched.

Canadian Blood Services, the Health Association of Afri­can Canadians and the United African-Canadian Women’s Association Sickle Cell Ane­mia Project held a special clin­ic Thursday to attract donors.

Source:  NovaScotiaNews.com

Aplastic Anemia Treatment Advance

A study recently released says it now knows where stem cells originate.    Why is this important in the treatment of Aplastic Anemia?  If doctor's and researchers know where the body creates stem cells, then they can try to recreate that environment and grow stem cells in a lab.  Do that and you have a treatment option for Aplastic Anemia.

Here's the article:

FRIDAY, March 7 (HealthDay News) -- Blood stem cells, which later differentiate into all types of blood cells, originate and are nurtured in the placenta, a U.S. study finds.

This finding may help researchers replicate the specific embryonic microenvironment necessary to grow blood stem cells in the lab so doctors can treat patients with diseases such as leukemia and aplastic anemia, said senior author Dr. Hanna Mikkola, a researcher in the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California, Los Angeles (UCLA).

"It was a big mystery, where these cells originated. This is the first time we can really say definitively that blood stem cells are generated in the placenta. There's no more speculation," Mikkola said in a prepared statement.

The discovery, reported in the March 6 issue of Cell Stem Cell, was made in research with mice. The researchers are now working to replicate it in humans.

"If we want to fully harness the potential of embryonic stem cells to treat disease, it's critical for us to learn how to make tissue-specific stem cells. We can learn that by studying what happens during embryonic development," said Mikkola, an assistant professor of molecular, cell and developmental biology and a researcher at UCLA's Jonsson Comprehensive Cancer Center.

In previous research, Mikkola and her colleagues found the placenta contained a large supply of stem cells, but the researchers weren't sure if these stem cells were created in the placenta or originated elsewhere and migrated to the placenta to self-renew.

In this new study, Mikkola's team examined a unique mouse model, a mouse embryo without a heartbeat. Because there was no blood circulation, the researchers were able to find the blood stem cells at their point of origin in the placenta.

"Using this model, we identified that the placenta has the potential to make hematopoietic [blood] stem cells with full differentiation ability to create all the major lineages of blood cells. The placenta acts as a sort of kindergarten for these newly made blood stem cells, giving them the first education they need," Mikkola explained.

Source:  USNews.com